This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Chanrx Corp., Chantest, Inc., The United States of America. Active years: 2004-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2004-2013
Title: Naresh Chand: Innovator in Cardiac Arrhythmia Treatment
Introduction
Naresh Chand is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of cardiac health, particularly in the treatment of cardiac arrhythmia. With a total of 3 patents to his name, his work has the potential to impact many lives.
Latest Patents
Chand's latest patents focus on methods for reducing the recurrence of cardiac arrhythmia. One of his key inventions involves administering vanoxerine (GBR 12909) or its pharmaceutically acceptable derivatives to mammals in need. This innovative approach aims to prevent or treat cardiac arrhythmia effectively. Another patent also emphasizes similar methods for treating cardiac arrhythmia, showcasing his dedication to advancing medical treatments in this area.
Career Highlights
Throughout his career, Naresh Chand has worked with various companies, including Chanrx Corp. and Chantest, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the medical field.
Collaborations
Chand has collaborated with notable individuals in his field, including his coworker Arthur M Brown. These partnerships have likely enhanced his research and development efforts.
Conclusion
Naresh Chand's work in cardiac arrhythmia treatment exemplifies the impact of innovation in healthcare. His patents and collaborations reflect a commitment to improving patient outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile